LOUISVILLE, Ky. / Apr 09, 2025 / Business Wire / Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today released its 2024 Impact Report, showcasing the company’s dedication to improving health outcomes and supporting communities across the nation. The report underscores Humana's efforts to improve member outcomes, advance environmental sustainability, and foster a culture of belonging and well-being among its employees, while contributing to a more effective and equitable healthcare system.
"At Humana, our responsibility goes beyond just business. We are committed to investing in our teammates, our communities, and the environment to create a healthier future for everyone," says Jim Rechtin, Humana President and CEO. “The work we do is deeply personal. It’s about the trust people place in us to be there when they need us most.”
The 2024 Impact Report showcases Humana's impacts on communities, the dedication of employees and leaders, and how Humana is improving health outcomes through innovation and integrated care. The report is focused on efforts in four key areas: people, community, the healthcare system, and the environment.
For each person
In 2024, Humana focused on creating tailored care plans for each member, significantly investing in preventive health measures to ensure optimal health outcomes. This approach included expanding access to high-quality care for CenterWell patients, enhancing personalized support, and fostering a culture of well-being among employees. By prioritizing these initiatives, Humana aimed to deliver exceptional healthcare experiences and outcomes for all.
For each community
Humana continues to invest in communities through affordable housing, local health initiatives and volunteering to enhance the quality of life for their members, patients, and employees.
For the healthcare system
By refining clinical excellence, integrating value-based care models, and fostering innovative healthcare research and interoperability, Humana enhanced healthcare delivery and outcomes. The company's commitment to supplier diversity also strengthened partnerships and improved services, shaping a more inclusive and effective healthcare system.
For the environment
Humana aims to create healthier surroundings for its patients, employees, and the broader community by prioritizing eco-friendly initiatives. It is committed to enhancing the connection between human health and environmental health, within its operations and in the communities it serves. Humana launched initiatives to reduce the company's carbon footprint, promote sustainable practices, reduce resource waste, and empower employees to do the same.
To learn more about Humana’s impact and continuing work to make it easier for people to achieve their best health, read the full 2024 Humana Impact Report.
About Humana
Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.
Last Trade: | US$290.40 |
Daily Change: | 3.62 1.26 |
Daily Volume: | 169,517 |
Market Cap: | US$34.970B |
February 11, 2025 November 12, 2024 October 30, 2024 October 24, 2024 October 23, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load